Solid Biosciences Llc Stock Price on April 22, 2024

SLDB Stock  USD 4.49  0.29  6.07%   
Below is the normalized historical share price chart for Solid Biosciences LLC extending back to January 26, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Solid Biosciences stands at 4.49, as last reported on the 26th of March, with the highest price reaching 4.86 and the lowest price hitting 4.45 during the day.
IPO Date
26th of January 2018
200 Day MA
6.1138
50 Day MA
4.3293
Beta
1.977
 
Covid
If you're considering investing in Solid Stock, it is important to understand the factors that can impact its price. Solid Biosciences appears to be very risky, given 3 months investment horizon. Solid Biosciences LLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0401, which indicates the firm had a 0.0401 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Solid Biosciences LLC, which you can use to evaluate the volatility of the company. Please review Solid Biosciences' Coefficient Of Variation of 2878.34, risk adjusted performance of 0.0382, and Semi Deviation of 4.98 to confirm if our risk estimates are consistent with your expectations.
  
At present, Solid Biosciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to about 41.4 K, whereas Total Stockholder Equity is forecasted to decline to about 89.1 M. . At present, Solid Biosciences' Price To Sales Ratio is projected to drop slightly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 1.25, whereas Price Earnings Ratio is forecasted to decline to (1.37). Solid Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0401

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsSLDB
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.51
  actual daily
67
67% of assets are less volatile

Expected Return

 0.3
  actual daily
6
94% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
3
97% of assets perform better
Based on monthly moving average Solid Biosciences is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Solid Biosciences by adding it to a well-diversified portfolio.
Price Book
2.6989
Enterprise Value Ebitda
(3.69)
Price Sales
3.6454
Shares Float
39.3 M
Wall Street Target Price
16.7

Solid Biosciences Main Headline on 22nd of April 2024

Filed transaction by Solid Biosciences LLC Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Solid Biosciences Valuation on April 22, 2024

It is possible to determine the worth of Solid Biosciences on a given historical date. On April 22, 2024 Solid was worth 8.85 at the beginning of the trading date compared to the closed value of 9.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Solid Biosciences stock. Still, in general, we apply an absolute valuation method to find Solid Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Solid Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Solid Biosciences' related companies.
 Open High Low Close Volume
  9.13    9.34    8.66    8.70    113,857  
04/22/2024
  8.85    9.25    8.54    9.04    187,755  
  9.06    9.61    8.95    9.11    297,274  
Backtest Solid Biosciences  |  Solid Biosciences History  |  Solid Biosciences Valuation   PreviousNext  
Open Value
8.85
9.04
Closing Value
31.37
Upside

Solid Biosciences Trading Date Momentum on April 22, 2024

On April 23 2024 Solid Biosciences LLC was traded for  9.11  at the closing time. The top price for the day was 9.61  and the lowest listed price was  8.95 . The trading volume for the day was 297.3 K. The trading history from April 23, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 0.77% . The trading price change against the current closing price is 7.30% .

Solid Biosciences LLC Fundamentals Correlations and Trends

By evaluating Solid Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Solid Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Solid financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Solid Biosciences Stock history

Solid Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Solid is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Solid Biosciences LLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Solid Biosciences stock prices may prove useful in developing a viable investing in Solid Biosciences
Last ReportedProjected for Next Year
Common Stock Shares Outstanding40.8 M42.9 M
Net Loss-77.4 M-81.3 M

Solid Biosciences Quarterly Net Working Capital

127.05 Million

Solid Biosciences Stock Technical Analysis

Solid Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Solid Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Solid Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Solid Biosciences Period Price Range

Low
March 26, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Solid Biosciences LLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Solid Biosciences March 26, 2025 Market Strength

Market strength indicators help investors to evaluate how Solid Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Solid Biosciences shares will generate the highest return on investment. By undertsting and applying Solid Biosciences stock market strength indicators, traders can identify Solid Biosciences LLC entry and exit signals to maximize returns

Solid Biosciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Solid Biosciences' price direction in advance. Along with the technical and fundamental analysis of Solid Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Solid to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Solid Stock analysis

When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities